Document Detail


Chloasma--the mask of pregnancy.
MedLine Citation:
PMID:  19140277     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chloasma is a required hypermelanosis of sun-exposed areas occurred during pregnancy and it can affect 50-70% of pregnant women. It presents as symmetric hyperpigmented macules, which can confluent or punctuate. The most common locations are the cheeks, the upper lip, the chin and the forehead. The exact mechanism by which pregnancy affects the process of melanogenesis is unknown. Estrogen, progesterone, and melanocyte-stimulating hormone (MSH) levels are normally increased during the third trimester of pregnancy. However, nulliparous patients with chloasma have no increased levels of estrogen or MSH. In addition, the occurrence of melasma with estrogen- and progesterone-containing oral contraceptive pills has been reported. The observation that postmenopausal woman who are given progesterone develop melasma, while those who are given only estrogen do not, implicates progesterone as playing a critical role in the development of melasma. UV-B, UV-A, and visible light are all capable of stimulating melanogenesis. The condition is self-limited; however spontaneous resolution is time-consuming and may take months to resolve normal pigmentation. Therefore, it is worthwhile to prevent the onset of chloasma, by strict photoprotection. Prudent measures to avoid sun exposure include hats and other forms of shade combined with the application of a broad-spectrum sunscreen at least daily. Sunscreens containing physical blockers, such as titanium dioxide and zinc oxide, are preferred over chemical blockers because of their broader protection. Chloasma can be difficult to treat. Quick fixes with destructive modalities (eg, cryotherapy, medium-depth chemical peels, lasers) yield unpredictable results and are associated with a number of potential adverse effects. The mainstay of treatment remains topical depigmenting agents. Hydroquinone (HQ) is most commonly used.
Authors:
Ivan Bolanca; Zeljana Bolanca; Krunoslav Kuna; Ante Vuković; Neven Tuckar; Radoslav Herman; Goran Grubisić
Related Documents :
21378477 - Acute myelogenous leukemia developed at the 26th week of gestation.
23099117 - Angiopoietin-1 and angiopoietin-2 as serum biomarkers for ectopic pregnancy and missed ...
21501457 - Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths.
21239787 - Pregnancy and commonly used drugs in hematology practice.
1379267 - The value of serum levels of oestradiol, progesterone and beta-human chorionic gonadotr...
7926087 - Assisted fertilization with intracytoplasmic sperm injection.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Collegium antropologicum     Volume:  32 Suppl 2     ISSN:  0350-6134     ISO Abbreviation:  Coll Antropol     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2009-01-13     Completed Date:  2009-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003354     Medline TA:  Coll Antropol     Country:  Croatia    
Other Details:
Languages:  eng     Pagination:  139-41     Citation Subset:  IM    
Affiliation:
University Department of Obstetrics and Gynecology, University Hospital Sestre milosrdnice, Zagreb, Croatia. ivan.bolanca@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Dermatologic Agents / therapeutic use
Female
Humans
Melanosis* / drug therapy,  etiology,  physiopathology,  prevention & control
Photosensitivity Disorders* / drug therapy,  etiology,  physiopathology,  prevention & control
Pregnancy
Pregnancy Complications* / drug therapy,  physiopathology,  prevention & control
Chemical
Reg. No./Substance:
0/Dermatologic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inequalities in health related quality of life in Primorsko-goranska County, Croatia. How healthy ar...
Next Document:  Trends, habits and attitudes towards suntanning.